{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T21:09:39Z","timestamp":1780088979882,"version":"3.54.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","jocn-journal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.jocn.2024.05.016","type":"journal-article","created":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T23:01:16Z","timestamp":1715900476000},"page":"76-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Effect of intravenous immunoglobulin and plasmapheresis on nerve conduction parameters compared to the natural course of Guillain-Barr\u00e9 syndrome"],"prefix":"10.1016","volume":"125","author":[{"given":"Jayantee","family":"Kalita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roopali","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mritunjai","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2024.05.016_b0005","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S0140-6736(21)00517-1","article-title":"Guillain-Barr\u00e9 syndrome","volume":"397","author":"Shahrizaila","year":"2021","journal-title":"Lancet"},{"issue":"1123\u20139","key":"10.1016\/j.jocn.2024.05.016_b0010","article-title":"A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barr\u00e9 syndrome. Dutch Guillain-Barr\u00e9 Study Group","volume":"326","author":"van der Mech\u00e9","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocn.2024.05.016_b0015","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/ana.410410304","article-title":"The French cooperative group on plasma exchange in Guillain-Barr\u00e9 Syndrome","volume":"41","author":"Appropriate number of plasma exchanges in Guillain-Barr\u00e9 syndrome","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2024.05.016_b0020","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1080\/1744666X.2016.1193006","article-title":"Guillain-Barr\u00e9 syndrome: causes, immunopathogenic mechanisms and treatment","volume":"12","author":"Jasti","year":"2016","journal-title":"Expert Rev Clin Immunol"},{"issue":"2","key":"10.1016\/j.jocn.2024.05.016_b0025","first-page":"CD001798","article-title":"Plasma exchange for Guillain-Barr\u00e9 syndrome","volume":"27","author":"Chevret","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jocn.2024.05.016_b0030","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1136\/jnnp-2016-314862","article-title":"Treatment dilemmas in Guillain-Barr\u00e9 syndrome","volume":"88","author":"Verboon","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jocn.2024.05.016_b0035","series-title":"Clinical Neurophysiology: nerve conduction, electromyography, evoked potential","author":"Misra","year":"2020"},{"key":"10.1016\/j.jocn.2024.05.016_b0040","doi-asserted-by":"crossref","first-page":"369","DOI":"10.4103\/0028-3886.314529","article-title":"Utility of serial nerve conduction studies in the electrodiagnosis of Guillain-Barre Syndrome","volume":"69","author":"Mani","year":"2021","journal-title":"Neurol India"},{"key":"10.1016\/j.jocn.2024.05.016_b0045","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.4103\/0028-3886.359245","article-title":"Prognostic Significance of Serial Nerve Conduction in GB Syndrome","volume":"70","author":"Kalita","year":"2022","journal-title":"Neurol India"},{"key":"10.1016\/j.jocn.2024.05.016_b0050","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/jnnp-2014-307815","article-title":"Electrophysiological diagnosis of Guillain-Barr\u00e9 syndrome subtype: could a single study suffice?","volume":"86","author":"Rajabally","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"420","key":"10.1016\/j.jocn.2024.05.016_b0055","article-title":"Nerve conduction studies in Guillain-Barr\u00e9 syndrome: Influence of timing and value of repeated measurements","volume":"15","author":"Rath","year":"2021","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jocn.2024.05.016_b0060","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1136\/jnnp.2010.208538","article-title":"Pitfalls in electrodiagnosis of Guillain-Barr\u00e9 syndrome subtypes","volume":"81","author":"Uncini","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Suppl","key":"10.1016\/j.jocn.2024.05.016_b0065","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/ana.410270707","article-title":"Assessment of current diagnostic criteria for Guillain-Barr\u00e9 syndrome","volume":"27","author":"Asbury","year":"1990","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2024.05.016_b0070","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0140-6736(78)92644-2","article-title":"Controlled trial prednisolone in acute polyneuropathy","volume":"2","author":"Hughes","year":"1978","journal-title":"Lancet"},{"issue":"780\u20138","key":"10.1016\/j.jocn.2024.05.016_b0075","article-title":"Electrophysiological classification of Guillain-Barr\u00e9 syndrome: clinical associations and outcome. Plasma Exchange\/Sandoglobulin Guillain-Barr\u00e9 Syndrome Trial Group","volume":"44","author":"Hadden","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2024.05.016_b0080","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/j.clinph.2017.03.048","article-title":"Optimizing the electrodiagnostic accuracy in Guillain-Barr\u00e9 syndrome subtypes: Criteria sets and sparse linear discriminant analysis","volume":"128","author":"Uncini","year":"2017","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.jocn.2024.05.016_b0085","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/mus.25577","article-title":"Electrodiagnosis of reversible conduction failure in Guillain-Barr\u00e9 syndrome","volume":"56","author":"Chan","year":"2017","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jocn.2024.05.016_b0090","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1111\/ene.15500","article-title":"Outcome of Guillain-Barr\u00e9 syndrome following intravenous immunoglobulin compared to natural course","volume":"29","author":"Kalita","year":"2022","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.jocn.2024.05.016_b0095","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/mus.880080609","article-title":"Sequential electrodiagnostic abnormalities in acute inflammatory demyelinating polyradiculoneuropathy","volume":"8","author":"Albers","year":"1985","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jocn.2024.05.016_b0100","article-title":"Guillain-Barr\u00c9 syndrome subtype diagnosis: A prospective multicentric European study","volume":"5","author":"Van den Bergh","year":"2018","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jocn.2024.05.016_b0105","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1093\/brain\/awq260","article-title":"Conduction block in acute motor axonal neuropathy","volume":"133","author":"Kokubun","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.jocn.2024.05.016_b0110","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/ana.410440210","article-title":"IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barr\u00e9 syndrome","volume":"44","author":"Kuwabara","year":"1998","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2024.05.016_b0115","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/1531-8249(199902)45:2<168::AID-ANA6>3.0.CO;2-6","article-title":"Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barr\u00e9 syndrome","volume":"45","author":"Ho","year":"1999","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2024.05.016_b0120","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/ana.410330402","article-title":"Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China","volume":"33","author":"McKhann","year":"1993","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2024.05.016_b0125","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1586\/ern.09.43","article-title":"Electrophysiologic and immunopathologic correlates in Guillain-Barr\u00e9 syndrome subtypes","volume":"9","author":"Uncini","year":"2009","journal-title":"Expert Rev Neurother"},{"issue":"27","key":"10.1016\/j.jocn.2024.05.016_b0130","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1523\/JNEUROSCI.4401-06.2007","article-title":"Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers","volume":"11","author":"Susuki","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.jocn.2024.05.016_b0135","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1093\/brain\/awq119","article-title":"Anti-GD1a antibodies activate complement and calpain to injure distal motor nodes of Ranvier in mice","volume":"133","author":"McGonigal","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.jocn.2024.05.016_b0140","doi-asserted-by":"crossref","first-page":"18562","DOI":"10.1038\/s41598-022-19547-0","article-title":"Reversible conduction failure in acute inflammatory demyelinating polyneuropathy","volume":"12","author":"Kim","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.jocn.2024.05.016_b0145","doi-asserted-by":"crossref","first-page":"714","DOI":"10.3389\/fneur.2019.00714","article-title":"Electrophysiological Subtypes and Prognostic Factors of Guillain-Barre Syndrome in Northern China","volume":"10","author":"Tian","year":"2019","journal-title":"Front Neurol"},{"key":"10.1016\/j.jocn.2024.05.016_b0150","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jocn.2020.04.059","article-title":"Electrophysiological subtypes and associated prognosis factors of Mexican adults diagnosed with Guillain-Barr\u00e9 syndrome, a single center experience","volume":"80","author":"L\u00f3pez-Hern\u00e1ndez","year":"2020","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.jocn.2024.05.016_b0155","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.expneurol.2018.05.009","article-title":"Internode length is reduced during myelination and remyelination by neurofilament medium phosphorylation in motor axons","volume":"306","author":"Villal\u00f3n","year":"2018","journal-title":"Exp Neurol"},{"key":"10.1016\/j.jocn.2024.05.016_b0160","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1177\/1352458508095731","article-title":"Outcome measures for trials of remyelinating agents in multiple sclerosis: retrospective longitudinal analysis of visual evoked potential latency","volume":"15","author":"Niklas","year":"2009","journal-title":"Mult Scler"},{"key":"10.1016\/j.jocn.2024.05.016_b0165","doi-asserted-by":"crossref","first-page":"20180086","DOI":"10.1259\/bjr.20180086","article-title":"Evaluation of optic nerve functions in subacute combined degeneration using visual evoked potential and diffusion tensor imaging-a pilot study","volume":"91","author":"Kalita","year":"2018","journal-title":"Br J Radiol"},{"key":"10.1016\/j.jocn.2024.05.016_b0170","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1212\/WNL.0b013e3181cff735","article-title":"Axonal variant of Guillain-Barre syndrome associated with Campylobacter infection in Bangladesh","volume":"74","author":"Islam","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.jocn.2024.05.016_b0175","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jfma.2012.08.011","article-title":"Clinical and electrophysiologic features of childhood Guillain-Barr\u00e9 syndrome in Northeast China","volume":"113","author":"Ye","year":"2014","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.jocn.2024.05.016_b0180","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/acn3.51984","article-title":"Radiologic grading scores enhance clinical model's prognostic ability for Guillain-Barr\u00e9 syndrome","volume":"11","author":"Fang","year":"2024","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.jocn.2024.05.016_b0185","doi-asserted-by":"crossref","first-page":"3646","DOI":"10.1111\/ene.16073","article-title":"European Academy of Neurology\/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain-Barr\u00e9 syndrome","volume":"30","author":"van Doorn","year":"2023","journal-title":"Eur J Neurol"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586824002017?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586824002017?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T01:04:01Z","timestamp":1717635841000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586824002017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":37,"alternative-id":["S0967586824002017"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2024.05.016","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of intravenous immunoglobulin and plasmapheresis on nerve conduction parameters compared to the natural course of Guillain-Barr\u00e9 syndrome","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2024.05.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}